MedTrace Logo

Intensive Glycemic Control for Congestive Heart Failure Exacerbation

NCT00812253 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2018-01-02

Study results available
· View outcomes & findings →

Summary

Patients with heart failure often have high blood sugar (glucose).

Conditions

Interventions

DRUG

Intravenous insulin

Half of subjects will receive insulin through the intravenous route while the other half will receive 4 injections per day.

DRUG

Subcutaneous insulin

Half of subjects will receive insulin through the intravenous route while the other half will receive 4 injections per day.

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Kathleen Dungan

    lead OTHER

Principal Investigators

  • Kathleen M Dungan, MD · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2013-09-30
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00812253 on ClinicalTrials.gov